Ronald M. Evans

Dr. Ronald M. Evans, born on April seventeenth, nineteen forty-nine, is a distinguished American biologist renowned for his groundbreaking work in the field of nuclear hormone receptors. As the Professor and Head of the Gene Expression Laboratory at the Salk Institute for Biological Studies in La Jolla, California, he also holds the prestigious March of Dimes Chair in Molecular and Developmental Biology. His research has significantly advanced our understanding of how lipophilic hormones and drugs influence developmental and metabolic pathways in both animals and humans.

Evans earned his Bachelor of Science and PhD from UCLA in nineteen seventy-four, followed by postdoctoral training at Rockefeller University under the mentorship of James E. Darnell. He joined the faculty at the Salk Institute in nineteen seventy-eight and has since held adjunct professorships in biology, Biomedical Sciences, and Neuroscience at UCSD in various years, including nineteen eighty-five, nineteen eighty-nine, and nineteen ninety-five. In nineteen ninety-eight, he was appointed the March of Dimes Chair in Molecular and Developmental Neurobiology.

His pioneering research on nuclear hormone receptors has garnered him over forty prestigious awards and honors, including the March of Dimes Prize in Developmental Biology in two thousand three and the Albert Lasker Award for Basic Medical Research in two thousand four. His accolades also include the Harvey Prize in two thousand six, the Gairdner Foundation International Award in two thousand six, the Albany Medical Center Prize in two thousand seven, the Wolf Prize in Medicine in two thousand twelve, and the Louisa Gross Horwitz Prize in two thousand eighteen.

Dr. Evans is a member of several esteemed organizations, including the National Academy of Sciences since nineteen eighty-nine, the American Society for Microbiology since nineteen ninety-three, and the American Academy of Arts and Sciences since nineteen ninety-seven. He has also been recognized as a member of the National Academy of Medicine since two thousand three, the European Molecular Biology Organization since two thousand six, and the American Philosophical Society since two thousand seven. In two thousand fourteen, he was elected as a fellow of the American Association for Cancer Research, and in two thousand eighteen, he was named an AAAS fellow and became a member of the National Academy of Inventors.